Background
Even though ART improves life expectancy and decreased mortality, they are now developing high prevalence of co-morbidities due to emerging of treatment-related metabolic complications. However, in Ethiopia there are a few reports about prevalence of Diabetes Mellitus (DM) among HIV patients. This study explores the magnitude of DM and associated factors among HIV-infected individuals on follow-up care.

Methods
A cross-sectional Study design was conducted in Kuyu General Hospital from February 2021 - March 2021. Adults with HIV-positive (aged ≥18 years) who were on ART included. Systematic random sampling was used to select 294 HIV-positive adults. Data were collected by pre-tested structured questionnaire and Anthropometric parameters, capillary and venous blood samples were collected by trained and experienced data collectors. Clinical data was obtained from patients’ folder and from results of laboratory tests. Descriptive analysis like frequency and percentage were conducted. To identify associated factors bivariate and multivariable binary logistic regression was fitted. In multivariate analysis P-value <0.05 at 95% confidence interval was considered as statistically significant.

Results
The age of the HIV-infected individuals enrolled was ranged from 18-67 years. Among 294 adults, DM was detected in 21(7.14%) patients on ART medication. The magnitude among females was 12(5.5%) and 9(7.5%) among males. In the multivariate analysis, hypertension (AOR=3.66, 95% CI: 1.2-11), increased Total cholesterol (AOR=3.9, 95% CI: 1.07-14), aged 45 or more years (AOR=3.5, 95% CI: 1.05-11.6) and longer duration of using ART (AOR=4.2, 95% CI: 1.2-14.6) were statistically significantly associated with DM.

Conclusion
The prevalence of DM among HIV-infected adults on ART follow-up was high. Older age, hypertension, total cholesterol and duration of using ART were associated with a higher prevalence of DM. It is better care providers to conduct DM screening, checkup for hypertension and lipid profiles for all HIV-infected individuals and provide integrated care for comorbid patients.